|
|
|
Do antibiotic-impregnated central lines prevent catheter-related bloodstream infection?
Lead author's name: Raad I
Three-part Clinical Question: Patients: hospital patients requiring triple-lumen CVCs Intervention: antibiotic impregnation minocycline and rifampin or untreated central venous catheters Outcomes: catheter colonisation and catheter related bloodstream infection (CRBSI)
Search Terms: Central venous catheters, Minocycline and rifampin-impregnated catheters, Bloodstream infection, Infectious complications
The Study: Randomised, double-blind controlled trial with intention-to treat analysis
The Study Patients: 298 catheters in 281
patients Control group (standard CVC) n= 237; 180
analysed Experimental group (impregnated CVC) n=228; 187 analysed
The Evidence:
EBM questions:
1) Do the methods allow accurate testing of the hypothesis? Yes.
2) Do the statistical tests correctly test the results to allow differentiation of statistically significant results? Yes
3) Are conclusions valid in light of the results? Yes
4) Did results get omitted, and why? Yes, 32 catheters were not cultured
5) Did they suggest areas of further research? Yes, additional RCTs of antibiotic CVCs for short and long term use
6) Did they make any recommendations based on the results and were they appropriate? Yes, antibiotic impregnated catheters reduce the incidence of CRBSI. Yes.
7) Is the study relevant to my clinical practice? No, these catheters are unavailable in the UK
8) What level of evidence does this study represent? 1+
9) What grade of recommendation can I make on this result alone? B
10) What grade of recommendation can I make when this study is considered along with other available evidence? B
11) Should I change my practice because of these results? Probably not
12) Should I audit my current practice because of these results? No, but you should be auditing CRBSI rates anyway.
Appraised by Dr David Swann, Consultant, ICU, Royal Infirmary of Edinburgh. June 2005
Email: d.g.swann@ad.ac.uk
Edited by CC Kill by Date: 2010
©SICS EBMG 2002
| |||||||||||||||||||||||